InsidersTradesSigma
Explore the detailed record of transactions filed by McMinn Rachel, Chief Executive Officer. Officer active across 1 companies, notably Neurogene Inc.. In total, 2 reports have been logged. The latest transaction was filed on 20 February 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
2 of 2 declarations
Rachel McMinn is the Chief Executive Officer of Neurogene Inc. She leads the company, focusing on growth strategy and innovation. Her leadership is crucial for achieving organizational goals and strengthening the market position of the firm.